"Black Panther: The Album" debuted atop the Billboard 200 this weekend after selling 154,000 copies in its first week, according to Nielsen Music.
That number understates the success of the album, a collection of songs curated by Grammy-winning rapper Kendrick Lamar. Billboard hasn't yet factored in the additional 61,300 copies sold over the weekend after the film came out.
To determine the number of copies sold, the music industry uses a formula that incorporates physical albums, digital albums, digital singles and song streams.
The album has been particularly big for streaming: Nielsen's data shows that the songs combined have been streamed nearly 190 million times since the album was released February 9. About 50 million of those streams were this weekend alone.
"This is much bigger than just a music release. It's much bigger than just a compilation album," said David Bakula, senior vice president of analytics at Nielsen Entertainment.
Hot High Tech Stocks To Invest In 2021: Veritiv Corporation(VRTV)
Veritiv Corporation ("Veritiv" or the "Company" and sometimes referred to in this Annual Report on Form 10-K as "we", "our", "us", or "ourselves") is a leading North American business-to-business distributor of print, publishing, packaging, and facility solutions. Additionally, Veritiv provides logistics and supply chain management solutions to its customers. Veritiv was established in 2014, following the merger of International Paper Company's ("International Paper" or "Parent") xpedx distribution solutions business and UWW Holdings, Inc. ("UWWH"), the parent company of Unisource. Independently, the two companies achieved past success by continuously upholding high standards of efficiency and customer focus. Through leveraging this combined history of operational excellence, Veritiv evolved into one team shaping its success through exceptional service, innovative people and consistent values. Advisors' Opinion:
- [By Max Byerly]
Veritiv Corp (NYSE:VRTV) has been assigned a consensus recommendation of “Hold” from the eight research firms that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $33.50.
- [By Shane Hupp]
Veritiv (NYSE:VRTV) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.
Western Gas Partners (NYSE:WES) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.
Hot High Tech Stocks To Invest In 2021: Sarepta Therapeutics, Inc.(SRPT)
We are a biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare, infectious and other diseases. Applying our proprietary, highly-differentiated and innovative platform technologies, we are able to target a broad range of diseases and disorders through distinct RNA-targeted mechanisms of action. We are primarily focused on rapidly advancing the development of our potentially disease-modifying DMD drug candidates, including our lead DMD product candidate, eteplirsen, designed to skip exon 51. On August 25, 2015, we announced the FDA filing of our NDA for eteplirsen for the treatment of DMD amenable to exon 51 skipping. The FDA postponed the Advisory Committee meeting for the review of the eteplirsen NDA previously scheduled for January 22, 2016 due to severe weather. Advisors' Opinion:
- [By ]
Some of my readers may know Sarepta (Nasdaq: SRPT) well. This $9 billion gene-therapy company already has an FDA-approved product. Exondys 51, the first-ever FDA-approved treatment for a rare but deadly genetic disease called Duchenne muscular dystrophy (DMD), is already on the market. And just last month, the FDA granted priority review for SRPT's second treatment for DMD, golodirsen, for DMD patients with a different genetic mutation.
- [By Dan Caplinger]
Wednesday was a bad day on Wall Street, as most major indexes finished lower. Small-cap stocks were hit harder than their large-cap counterparts, due in part to readings on the U.S. economy that signaled the possibility of a slowdown in the future. Moreover, downward pressure from some high-profile players weighed on overall market sentiment. NIO (NYSE:NIO), Brown-Forman (NYSE:BF-A) (NYSE:BF-B), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers. Here's why they did so poorly.
Hot High Tech Stocks To Invest In 2021: B2Gold Corp(BTG)
B2Gold Corp. (B2Gold) is a Canada-based gold producer with approximately four operating mines and one mine under construction. The Company has a portfolio of other evaluation and exploration projects in various countries, including Mali, Colombia, Burkina Faso, Finland, Chile and Nicaragua. Its material mineral properties consist of three mines and one mine under construction: Otjikoto mine, an open pit gold mine located approximately 300 kilometers north of Windhoek, the capital of Namibia (Otjikoto Mine); Masbate mine, an open pit gold mine, located near the northern tip of the island of Masbate, over 360 kilometers south-east of Manila (Masbate Gold Project); La Libertad mine, an open pit gold mine located over 110 kilometers due east of Managua and 32 kilometers northeast of Juigalpa, Nicaragua (La Libertad Mine), and Fekola gold project, an open pit gold mine under construction located approximately 40 kilometers south of the city of Kenieba, Mali (Fekola Project). Advisors' Opinion:- [By Neha Chamaria]
Newmont Mining
Mining $18.33 billion Franco-Nevada Streaming (gold, platinum group, and oil and gas) $14.51 billion Agnico-Eagle Mines (NYSE:AEM) Mining $10.4 billion Goldcorp Mining $9.67 billion Kirkland Lake Gold (NYSE:KL) Mining $7.62 billion Royal Gold Streaming (gold) $6 billion AngloGold Ashanti (NYSE:AU) Mining $5.4 billion Kinross Gold (NYSE:KGC) Mining $4.29 billion B2Gold (NYSEMKT:BTG) Mining $2.96 billion*Market capitalization as of March 13, 2019. Source: Yahoo! Finance.
- [By Max Byerly]
Get a free copy of the Zacks research report on B2Gold (BTG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Here is how other cryptocurrencies have performed in the last day:
Get Bitgem alerts: Zcash (ZEC) traded 2.6% lower against the dollar and now trades at $110.45 or 0.01761262 BTC. Bitcoin Gold (BTG) traded up 3.3% against the dollar and now trades at $25.07 or 0.00399774 BTC. Horizen (ZEN) traded down 3.4% against the dollar and now trades at $13.68 or 0.00218132 BTC. Bitcoin Private (BTCP) traded down 0.9% against the dollar and now trades at $2.49 or 0.00039650 BTC. Bitcoin Interest (BCI) traded down 4.4% against the dollar and now trades at $0.96 or 0.00015281 BTC. ZClassic (ZCL) traded 0.1% lower against the dollar and now trades at $3.20 or 0.00051056 BTC. BitcoinZ (BTCZ) traded 1% lower against the dollar and now trades at $0.0006 or 0.00000009 BTC. Zero (ZER) traded 5.1% lower against the dollar and now trades at $0.14 or 0.00002203 BTC. Hush (HUSH) traded 2.9% higher against the dollar and now trades at $0.10 or 0.00001645 BTC. VoteCoin (VOT) traded down 6.4% against the dollar and now trades at $0.0034 or 0.00000054 BTC.Bitgem Profile
No comments:
Post a Comment